Evidence map›Paper›PMID 39676968›Full record

ReviewACS omega2024

Constructions, Purifications and Applications of DNA-Antibody Conjugates: A Review.

Tao Wang, Xuelin Wang, Shuhong Luo, Peng Zhang, Na Li, Can Chen, Jianwen Li, Hao Shi, Hua Dong, Ruo-Pan Huang

Abstract readReview
In one paragraph

Review in ACS omega, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Tao WangRayBiotech Guangzhou Co., Ltd., 79 Ruihe Road, Huangpu District, Guangzhou, Guangdong 510535, China.ORCID https://orcid.org/0000-0002-6470-8724
Xuelin WangRayBiotech Life Inc., Peachtree Corners, Georgia 30092, United States.
Shuhong LuoRayBiotech Life Inc., Peachtree Corners, Georgia 30092, United States.
Peng ZhangRayBiotech Life Inc., Peachtree Corners, Georgia 30092, United States.
Na LiRayBiotech Life Inc., Peachtree Corners, Georgia 30092, United States.
Can ChenCollege of Life Sciences, Zhejiang University, Hangzhou 310058, China.
Jianwen LiDepartment of Chemistry, University of Georgia, Athens, Georgia 30602, United States.ORCID https://orcid.org/0000-0002-3936-937X
Hao ShiSchool of Life Science and Food Engineering, Huaiyin Institute of Technology, Huaian, Jiangsu 223003, China.
Hua DongDepartment of Biomedical Engineering, School of Materials Science and Engineering, South China University of Technology, Guangzhou 510641, China.
Ruo-Pan HuangRayBiotech Guangzhou Co., Ltd., 79 Ruihe Road, Huangpu District, Guangzhou, Guangdong 510535, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A DNA-antibody conjugate is a synthetic molecule that combines the unique functions of both an antibody and DNA. With the increased accessibility of commercialized kits, the procedure for constructing conjugates is simplified and the requirement for chemistry background is reduced. As a result, the difficulty of preparing a DNA-antibody conjugate has been significantly lowered. Therefore, the application of DNA-antibody conjugates has attracted more interest in recent years. The most common application of DNA-antibody conjugates is based on the amplifiable property of DNA through PCR. This includes single-conjugate-based immuno-PCR, paired-conjugates-based proximity ligation assay, and proximity extension assay. These methods achieve highly sensitive or specific detection of target proteins. The conjugated single stranded DNA molecules can also specifically hybridize with another strand containing its complementary sequence. This property can be used to selectively bind fluorophore labeled DNA strands, which plays an important role in tissue imaging and spatial omics. All these factors make DNA-antibody conjugates have a broad range of applications in research, diagnosis, and potentially therapy.

Identifiers

PMID39676968
PMCPMC11635685

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.